Invention Grant
- Patent Title: Aggrecanase inhibitors
- Patent Title (中): 聚集蛋白酶抑制剂
-
Application No.: US14422018Application Date: 2013-10-18
-
Publication No.: US09206139B2Publication Date: 2015-12-08
- Inventor: Timothy Barrett Durham , Jothirajah Marimuthu , Michael Robert Wiley
- Applicant: Eli Lilly and Company
- Applicant Address: US IN Indianapolis
- Assignee: Eli Lilly and Company
- Current Assignee: Eli Lilly and Company
- Current Assignee Address: US IN Indianapolis
- Agent James J. Sales
- International Application: PCT/US2013/065591 WO 20131018
- International Announcement: WO2014/066151 WO 20140501
- Main IPC: C07D233/78
- IPC: C07D233/78 ; C07D233/76 ; A61K31/417
Abstract:
The present invention provides compounds having the formula: wherein R1 is selected from methyl, ethyl, propyl, cyclopropyl, and dimethyl, or a pharmaceutically acceptable salt thereof, along with methods and intermediates for their preparation, and uses thereof.
Public/Granted literature
- US20150218107A1 AGGRECANASE INHIBITORS Public/Granted day:2015-08-06
Information query
